Trials / Unknown
UnknownNCT04871347
The Safety and Efficacy of TWP-101 in Patients With Advanced Solid Tumor
A Multi-center, Phase Ia/Ib, Open Clinical Study to Evaluate the Safety and Efficacy of TWP-101 in Patients With Advanced Solid Tumor
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (estimated)
- Sponsor
- Shandong TheraWisdom Biopharma Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, phase Ia/Ib, open clinical study to evaluate the safety and efficacy of TWP-101 in patients with advanced solid tumor. This study consists of two parts (Part A and Part B). Part A was a dose escalation study, and Part B was a dose expansion study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TWP-101 | IV infusion |
Timeline
- Start date
- 2021-08-30
- Primary completion
- 2023-06-30
- Completion
- 2023-12-31
- First posted
- 2021-05-04
- Last updated
- 2021-07-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04871347. Inclusion in this directory is not an endorsement.